The company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...

AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of its Allo Chassis-ready-to-use, immune-cloaked iPSC cell lines derived from ...

PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...

Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of ...

"We are excited to collaborat with PHC to unlock new possibilities in cell culture," explained Michael May, President and CEO ...

PHC has partnered with CCRM to boost cell quality with advanced T-cell expansion solutions. Takeaway Points  PHC has ...

Pluristyx, the leading provider of innovative induced pluripotent stem cells (iPSC), announces the issuance of the groundbreaking induced Allogeneic Cell Tolerance (iACT Stealth™) U.S. Patent No.

Stem cell technology is revolutionizing cosmetic procedures. These facelifts utilize adipose-derived stem cells, extracted ...